APAC Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Market Analysis


  • Type: Common Disease Area
  • Published : February 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5044

  • Format: PPT, PDF

APAC Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Market Analysis: Segmented by Drug type and By Surgery Outlook – Growth, Market Size, Future Prospects & Competitive Analysis, 2020–2028

SKU: 5044 Categories: ,

Report Description of the APAC Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Polycystic Ovarian Syndrome Treatment Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Polycystic Ovarian Syndrome Treatment market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

APAC Polycystic Ovarian Syndrome (PCOS/PCOD) Treatment Executive Summary

Polycystic ovary syndrome (PCOS) is a common hormonal endocrine disorder that affects women of childbearing age (15 to 49 years). According to the Centers for Disease Control & Prevention (CDC), polycystic ovary syndrome (PCOS) is the most common cause of female infertility. Also, the prevalence of polycystic ovarian syndrome in adolescents based on the Rotterdam criteria was found to be 11.04%, based on the National Institute of Health criteria, it was 3.39%, and based on Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03%, worldwide. The increasing burden of PCOS and no targeted therapy for PCOS being available in the market creates a need to develop therapies to treat them

Market Size and Key Findings

The APAC Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment Market size stood at around USD XX billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.3% during the forecast period.

The Asia Pacific region including China and India accounted for the major population base. The administrations in these countries are aiming at controlling the increasing prevalence of PCOS by accomplishing programs that support the analysis & therapeutics of this disorder and the required modification in lifestyle. These aspects are likely to spur the Asia Pacific market in the future.

Market Dynamics

Market Growth Drivers Analysis

The prevalence of the PCOS disease are growing which is fuelling growth of the global polycystic ovary syndrome (PCOS) treatment market. Additionally, growing awareness among the patient population about the availability of the treatment are fuelling growth of the polycystic ovary syndrome (PCOS) treatment market. The PCOS might lead to obesity, hirsutism, and infertility; hence, the awareness level in the people is increasing. This factor is boosting adoption of the polycystic ovary syndrome (PCOS) treatments and likely to fuel the polycystic ovary syndrome (PCOS) treatment market. Also, growing adoption of combination drugs coupled with rising adoption among the patients is expected to boost the global revenue of the polycystic ovary syndrome (PCOS) treatment market.

Market Restraints

Factors such as side effects associated with drugs such as weight gain, cardiovascular risks, increase insulin resistance, abnormal glucose tolerance, and thromboembolic events and Lack of drugs approved by regulatory bodies such as FDA (Food and Drug Administration) among many countries is a key factor hampering the growth of the polycystic ovarian syndrome treatment market. are expected to restrict the market growth during the forecast period

COVID-19 impact on “APAC Polycystic Ovarian Syndrome (PCOS / PCOD) Treatment Market” 

Various gynaecological procedures and nonessential treatment have been postponed owing to the current pandemic. Furthermore, non-COVID-19 related research is being delayed by various companies, which is leading to delayed product launches. Some disruptions in sourcing raw materials from impacted countries, such as China, were also observed in early 2020, but such disorders are unlikely to affect going forward. However, as previous restrictions are now being relaxed in several countries, the market growth will also resume.

Competitive Landscape

Key Players

The major market players are focusing on symptomatic treatments and several have their drugs in clinical trials, but not approved for marketing. There is a growing focus on surgeries, for which many medical devices are inclined towards. Some of the major players in the market are Bayer AG, Ferring BV, Merck KGaA, Novartis, Pfizer, and Takeda, Teva Pharmaceutical Industries Limited, among others.

Products in Pipeline

A detailed picture of the Polycystic ovary syndrome pipeline landscape is provided which includes the disease overview and Polycystic ovary syndrome treatment guidelines. The assessment part of the report embraces, in depth Polycystic ovary syndrome commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Polycystic ovary syndrome collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Notable Recent Deals

Evotec SE and Bayer AG announced the expansion of their partnership in women’s health indications with a new five-year, multi-target collaboration with participation from Celmatix Inc. to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (“PCOS”). Under the terms of the agreement, both companies will contribute drug targets and a comprehensive set of high-quality technology platforms to jointly develop innovative treatment options.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

There is a good growth potential in emerging markets and pharmaceutical drugs manufacturers are focusing on emerging economies in the Asia Pacific to target a large patient population. Also, effective reimbursement policies and reduction in the costs of drugs used for the treatment of PCOS is likely to increase the adoption of PCOS drugs across the Asia-Pacific region.

1. Report Description of the APAC Polycystic Ovarian Syndrome Treatment Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Polycystic Ovarian Syndrome Treatment Executive Summary
2.1 APAC Polycystic Ovarian Syndrome Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Polycystic Ovarian Syndrome Treatment Market
3.1 Market Growth Drivers Analysis
3.1.1 Growing prevalence of PCOS disease
3.1.2 Growing awareness on treatment of PCOS
3.1.3 Growing adoption of combination of drugs
3.2 Market Restraints Analysis
3.2.1 Side effect of the Drugs
3.2.2 Lack of Drugs approved by regulatory bodies
3.3 Covid-19 Market Impact Analysis
3.3.1 Negative impact on APAC PCOS Treatment Market
4. Polycystic Ovarian Syndrome Treatment Market Segmentation
4.1 By Drug Type Analysis:
4.1.1 Oral Contraceptives
4.1.2 Antiandrogens
4.1.3 Insulin-sensitizing Agent
4.1.4 Antidepressant
4.1.5 Anti-obesity
4.2 By Surgery Outlook Analysis:
4.2.1 Ovarian Wedge Resection
4.2.2 Laparoscopic Ovarian Drilling
4.2.3 Others
5. Polycystic Ovarian Syndrome Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Polycystic Ovarian Syndrome Treatment Market
6.4 Notable recent deals in Polycystic Ovarian Syndrome Treatment Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Merges & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Bayer AG Company overview
Product & Services, Strategies & Financials
7.2 Ferring BV Company overview
Product & Services, Strategies & Financials
7.3 Merck KGaA Company overview
Product & Services, Strategies & Financials
7.4 Novartis Company overview
Product & Services, Strategies & Financials
7.5 Pfizer Company overview
Product & Services, Strategies & Financials
7.6 Takeda Company overview
Product & Services, Strategies & Financials
7.7 Teva Pharmaceutical
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Polycystic Ovarian Syndrome Treatment market
9.2 Future Opportunities
10. Strategic Recommendations

Polycystic Ovarian Syndrome Treatment Market Segmentation

By Drug Type:

Based on drug type the market is sub-segmented into-

  • Oral Contraceptives
  • Antiandrogens
  • Insulin-sensitizing Agent
  • Antidepressant
  • Anti-obesity

By Surgery Outlook

Based on Surgery Outlook the market is sub-segmented into-

  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling
  • Others

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements